De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
AK Medical Holdings Toekomstige groei
Future criteriumcontroles 5/6
AK Medical Holdings zal naar verwachting groeien in winst en omzet met respectievelijk 28.7% en 24.7% per jaar. De winst per aandeel zal naar verwachting groeien met 28.3% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 12.9% zijn.
Belangrijke informatie
28.7%
Groei van de winst
28.3%
Groei van de winst per aandeel
| Medical Equipment winstgroei | 39.5% |
| Inkomstengroei | 24.7% |
| Toekomstig rendement op eigen vermogen | 12.9% |
| Dekking van analisten | Good |
| Laatst bijgewerkt | 10 Sep 2024 |
Recente toekomstige groei-updates
Recent updates
AK Medical Holdings Limited's (HKG:1789) Intrinsic Value Is Potentially 92% Above Its Share Price
Aug 30
Why We're Not Concerned Yet About AK Medical Holdings Limited's (HKG:1789) 25% Share Price Plunge
Jun 20It's Unlikely That Shareholders Will Increase AK Medical Holdings Limited's (HKG:1789) Compensation By Much This Year
Jun 11Returns On Capital At AK Medical Holdings (HKG:1789) Paint A Concerning Picture
May 27We Think AK Medical Holdings (HKG:1789) Can Stay On Top Of Its Debt
May 08Investors Appear Satisfied With AK Medical Holdings Limited's (HKG:1789) Prospects
Apr 21AK Medical Holdings Limited (HKG:1789) Analysts Are Reducing Their Forecasts For This Year
Apr 01AK Medical Holdings' (HKG:1789) Returns On Capital Not Reflecting Well On The Business
Jan 22Shareholders Should Be Pleased With AK Medical Holdings Limited's (HKG:1789) Price
Jan 04AK Medical Holdings (HKG:1789) Seems To Use Debt Rather Sparingly
Dec 12A Look At The Fair Value Of AK Medical Holdings Limited (HKG:1789)
Nov 09AK Medical Holdings (HKG:1789) Could Be Struggling To Allocate Capital
Sep 20AK Medical Holdings (HKG:1789) Could Easily Take On More Debt
Sep 03Investors Could Be Concerned With AK Medical Holdings' (HKG:1789) Returns On Capital
Jun 07Estimating The Fair Value Of AK Medical Holdings Limited (HKG:1789)
May 18Returns On Capital Signal Tricky Times Ahead For AK Medical Holdings (HKG:1789)
Feb 13Returns On Capital Signal Tricky Times Ahead For AK Medical Holdings (HKG:1789)
Nov 10Estimating The Fair Value Of AK Medical Holdings Limited (HKG:1789)
Sep 29Be Wary Of AK Medical Holdings (HKG:1789) And Its Returns On Capital
Aug 04Are Investors Undervaluing AK Medical Holdings Limited (HKG:1789) By 44%?
Jun 25There Are Reasons To Feel Uneasy About AK Medical Holdings' (HKG:1789) Returns On Capital
Apr 11Capital Allocation Trends At AK Medical Holdings (HKG:1789) Aren't Ideal
Oct 08Estimating The Intrinsic Value Of AK Medical Holdings Limited (HKG:1789)
Sep 20Analysts Are More Bearish On AK Medical Holdings Limited (HKG:1789) Than They Used To Be
Jul 27I Built A List Of Growing Companies And AK Medical Holdings (HKG:1789) Made The Cut
Jul 19AK Medical Holdings Limited (HKG:1789) Shares Could Be 39% Below Their Intrinsic Value Estimate
Jun 16The Returns On Capital At AK Medical Holdings (HKG:1789) Don't Inspire Confidence
Jun 01AK Medical Holdings Limited (HKG:1789) Analysts Are More Bearish Than They Used To Be
Apr 01Winst- en omzetgroeiprognoses
| Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
|---|---|---|---|---|---|
| 12/31/2026 | 2,098 | 414 | 253 | 411 | 6 |
| 12/31/2025 | 1,743 | 339 | 140 | 334 | 7 |
| 12/31/2024 | 1,387 | 270 | 112 | 284 | 6 |
| 6/30/2024 | 1,102 | 189 | -47 | 116 | N/A |
| 3/31/2024 | 1,098 | 185 | -105 | 75 | N/A |
| 12/31/2023 | 1,094 | 182 | -162 | 34 | N/A |
| 9/30/2023 | 1,132 | 197 | -141 | 38 | N/A |
| 6/30/2023 | 1,170 | 211 | -121 | 42 | N/A |
| 3/31/2023 | 1,111 | 208 | 0 | 143 | N/A |
| 12/31/2022 | 1,052 | 205 | 121 | 243 | N/A |
| 9/30/2022 | 949 | 156 | 200 | 315 | N/A |
| 6/30/2022 | 845 | 107 | 278 | 387 | N/A |
| 3/31/2022 | 803 | 100 | 189 | 282 | N/A |
| 12/31/2021 | 761 | 93 | 100 | 177 | N/A |
| 9/30/2021 | 883 | 178 | 35 | 120 | N/A |
| 6/30/2021 | 1,004 | 263 | -30 | 64 | N/A |
| 3/31/2021 | 1,020 | 288 | 43 | 135 | N/A |
| 12/31/2020 | 1,035 | 314 | 115 | 205 | N/A |
| 9/30/2020 | 1,002 | 307 | 116 | 199 | N/A |
| 6/30/2020 | 968 | 300 | 116 | 194 | N/A |
| 3/31/2020 | 947 | 284 | 77 | 169 | N/A |
| 12/31/2019 | 927 | 267 | 38 | 145 | N/A |
| 9/30/2019 | 845 | 235 | 35 | 147 | N/A |
| 6/30/2019 | 763 | 203 | 33 | 150 | N/A |
| 3/31/2019 | 682 | 174 | 44 | 139 | N/A |
| 12/31/2018 | 601 | 145 | 54 | 128 | N/A |
| 9/30/2018 | 543 | 136 | 71 | 131 | N/A |
| 6/30/2018 | 485 | 127 | 87 | 135 | N/A |
| 3/31/2018 | 429 | 116 | N/A | 126 | N/A |
| 12/31/2017 | 373 | 105 | N/A | 117 | N/A |
| 9/30/2017 | 345 | 100 | N/A | 119 | N/A |
| 6/30/2017 | 318 | 94 | N/A | 120 | N/A |
| 3/31/2017 | 294 | 86 | N/A | 95 | N/A |
| 12/31/2016 | 271 | 77 | N/A | 70 | N/A |
| 12/31/2015 | 206 | 65 | N/A | 36 | N/A |
| 12/31/2014 | 148 | 52 | N/A | 51 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: De verwachte winstgroei 1789 ( 28.7% per jaar) ligt boven de spaarquote ( 2.3% ).
Winst versus markt: De winst van 1789 ( 28.7% per jaar) zal naar verwachting sneller groeien dan de Hong Kong markt ( 12.2% per jaar).
Hoge groeiwinsten: De winst van 1789 zal naar verwachting de komende 3 jaar aanzienlijk groeien.
Omzet versus markt: De omzet van 1789 ( 24.7% per jaar) zal naar verwachting sneller groeien dan de markt Hong Kong ( 7.3% per jaar).
Hoge groei-inkomsten: De omzet van 1789 ( 24.7% per jaar) zal naar verwachting sneller groeien dan 20% per jaar.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Het rendement op eigen vermogen 1789 zal naar verwachting over 3 jaar laag zijn ( 12.9 %).